Folic Acid Supplementation During Methotrexate Immunosuppression Is Not Associated With Early Toxicity, Risk of Acute Graft-Versus-Host Disease or Relapse Following Hematopoietic Transplantation
Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705303
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2006
Authors
Publisher
Springer Nature